Kreon Epi (Pancreas Powder)

• Kreon Epi is used to replace deficient pancreatic enzymes in conditions that cause exocrine pancreatic insufficiency.
• Exocrine pancreatic insufficiency: Improves digestion and nutrient absorption by supplying lipase, protease, and amylase.
• Cystic fibrosis: Enhances breakdown of dietary fats and proteins, helping maintain nutritional status.
• Chronic pancreatitis: Reduces steatorrhea and abdominal discomfort by providing supplemental enzymes.

• Pancreas Powder contains a mixture of lipase, protease, and amylase that are released in the duodenum where they hydrolyze dietary triglycerides, proteins, and carbohydrates. By supplementing the endogenous pancreatic output, the preparation compensates for enzyme deficiency, allowing more optimal efficient macronutrient breakdown and absorption. The enzymes are enteric‑coated to protect them from gastric acid and become active at intestinal pH.

Pancreas Powder may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Abdominal discomfort or pain
• Flatulence and bloating
• Diarrhea or loose stools
• Nausea or vomiting
• Oily or fatty stools (steatorrhea)

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis, rash, swelling)
• Intestinal obstruction or blockage
• Acute pancreatitis exacerbation

When prescribing Kreon Epi, clinicians should consider several precautionary measures to ensure safe and effective use.

• Dose individualization: Adjust the enzyme dose based on the patient’s fat intake and clinical response.
• Monitor nutritional status: Regularly assess weight, vitamin levels, and stool fat content.
• Acid‑reducing therapy: Use proton‑pump inhibitors or H2 blockers to maintain adequate gastric pH for enzyme activity.
• Gastrointestinal obstruction: Avoid use in patients with known intestinal blockage or severe narrowing.
• Hypersensitivity: Discontinue if signs of allergic reaction such as rash or swelling appear.
• Store at ambient temperature: Keep below 25 °C in the original container, protected from moisture and light.

Pancreatic enzyme preparations can interact with other medicines, altering their effectiveness or safety.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: May bind enzymes and reduce their activity.
• Cholestyramine or other bile‑acid sequestrants: Can adsorb enzymes and diminish absorption.
• High‑dose proton‑pump inhibitors without appropriate timing: May excessively raise gastric pH, impairing enzyme activation.

Moderate Interactions (Monitor Closely)

• Warfarin: Enzyme therapy may affect vitamin K absorption, requiring INR monitoring.
• Oral contraceptives: Altered gut absorption could modify hormone levels.
• Antibiotics such as tetracycline: May chelate with enzymes, reducing efficacy.